Aratana Therapeutics Inc. | Mutual Funds
Mutual Funds that own Aratana Therapeutics Inc.
Franklin Small Cap Growth Fund
2,697,019
5.66%
0
0.48%
03/31/2018
FTIF SICAV - Franklin Biotechnology Discovery Fund
1,847,900
3.88%
0
0.42%
06/30/2018
General American Investors Fund
1,117,923
2.35%
250,323
0.38%
12/31/2017
Franklin Biotechnology Discovery Fund
1,102,000
2.31%
0
0.4%
03/31/2018
Vanguard Total Stock Market Index Fund
1,063,683
2.23%
0
0%
07/31/2018
iShares Russell 2000 ETF
934,778
1.96%
-498
0.01%
09/06/2018
MFS New Discovery Fund
840,532
1.76%
0
0.33%
07/31/2018
Williamsburg Invt. Trust - Davenport Small Cap Focus Fund
634,038
1.33%
0
2.2%
07/31/2018
Vanguard Extended Market Index Fund
561,516
1.18%
0
0%
07/31/2018
iShares Nasdaq Biotechnology ETF
540,483
1.12%
-7,077
0.03%
09/06/2018
| Address |
11400 Tomahawk Creek Parkway
Leawood Kansas 66211
United States
|
|
Employees
|
- |
| Website |
http://www.aratana.com |
| Updated |
07/08/2019 |
| Aratana Therapeutics, Inc. operates as a development stage biopharmaceutical company, which focuses on the licensing, development and commercialization of innovative prescription medications for pets or pet therapeutics. It delivers prescription medicines that address significant medical needs for cats and dogs. The firm licenses proprietary, patent-protected compounds from human pharmaceutical and biotechnology companies. |
